Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print 1 step closer to green chemistry and improved pharmaceuticals

1 step closer to green chemistry and improved pharmaceuticals

June 25, 2008

Researchers at the University of Copenhagen, Denmark, solve an important piece of the puzzle behind how proteins are shaped

Proteins are the workhorses of our cells. They help to digest our food, are at the core of our immune system, and literally shape our body from top to toe. Proteins also play an important role in biotechnology in the form of enzymes, which are important in the creation of anything from pharmaceuticals to bread, washing powder and much more. Their possibilities are virtually without limit.




To take advantage of their great potential, a detailed understanding of the three-dimensional shape of proteins is necessary. This is normally achieved through a complicated and expensive process in the laboratory. For years, researchers have tried to replace these experiments by computer simulations.

Now, two researchers at the Department of Biology at the University of Copenhagen, Assoc. professor Thomas Hamelryck and PhD-student Wouter Boomsma, have solved an important part of the problem of modeling the three dimensional shape of proteins. After 5 years of research, they have succeeded in developing a mathematical model that incorporates knowledge from physics, probability theory and geometry to describe the structure of proteins. This has given protein researchers a valuable new tool for the improved understanding of the shape and function of proteins.

"Each individual protein has its own unique chemical composition, consisting of 20 different amino acids in various different combinations. There are an endless number of such combinations, each giving rise to its own shape. We have developed a simple mathematical model that captures these different shapes. This means that it will become easier for industry and researchers to use proteins to achieve their goals. For example in the development of green chemistry, where dangerous chemicals are replaced with protein-based products, which are more environment friendly", says Thomas Hamelryck.

Thomas also points to the fact that their computer model can have a great impact on the pharmaceutical industry.

"Proteins and illness are highly related, and most pharmaceuticals are targeted at proteins in our body. As we increase our knowledge of these proteins, the chance of finding more efficient pharmaceuticals for illnesses such as cancer, diabetes and AIDS are greatly enhanced", Thomas continues.

The two researchers at the University of Copenhagen are currently collaborating closely with partners in the biotech industry to explore these possibilities.

University of Copenhagen



Related Pharmaceuticals Current Events and Pharmaceuticals News Articles Pharmaceuticals Current Events and Pharmaceuticals News RSS Pharmaceuticals Current Events and Pharmaceuticals News RSS
Approved lymphoma drug shows promise in early tests against bone cancer
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.

Researchers identify drug candidate for treating spinal muscular atrophy
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants.

UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin.

Clinical tests begin on medication to correct Fragile X defect
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability.

TGen seeks emergency FDA approval of new swine flu test
The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.

Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu, UAB Researcher Says
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.

Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

New drug aims to 'seek and destroy' many types of cancer
A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

Researchers find a key mechanism in the development of nerve cells
Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other.

Unlocking the secrets of the seafloor: The future of scientific ocean drilling
Close to 600 scientists from 21 countries met Sept. 23 - 25 2009 in Bremen, Germany, to outline major scientific targets for a new and ambitious ocean drilling research program.
More Pharmaceuticals Current Events and Pharmaceuticals News Articles
Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients

Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients
by Ray Moynihan (Author), Alan Cassels (Author)

Thirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high...

Saunders Pharmaceutical Word Book 2008

Saunders Pharmaceutical Word Book 2008
by Ellen Drake CMT FAAMT AHDI-F Educator of the Year Winner (Author), Randy Drake MS (Author)

Written by transcriptionists for transcriptionists, this drug reference lets you quickly locate the correct spelling and capitalization of more than 27,000 brand-name and generic drugs. It includes the corresponding uses of those drugs, cross-referencing of brand names to generics, and the usual methods of administration (e.g., capsule, IV, cream). To help you avoid errors, it also contains the indications (reasons for administration) of approved drugs and standard dosages.

Over 27,000 brand-name and generic drugs are included, with dosage forms, investigational drug names, chemotherapy protocols, trademarked dosage forms, drug categories/classes, and almost 2,000 medicinal herbs and natural remedies.Pharmaceutical information is organized specifically for the medical...

Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs

Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs
by Melody Petersen (Author)

An “angrily illuminating” (The New York Times) exposé of Big Pharma’s corrupting influence in America today

In the last thirty years, pharmaceutical companies have seized control of American medicine by putting their marketers in charge. They invent diseases in order to sell the pills that "cure" them. They sway doctors by giving them resort vacatopms, gourmet meals, and fistfuls of cash. They advertise prescription drugs at NASCAR races, on subways, and even in churches. Medicines can save lives, but the relentless promotion of these products has come at tremendous cost. Prescription pills taken as directed are estimated to kill one American every five minutes. More Americans are addicted to medications than cocaine. And roads have become less safe as the over-medicated...

  Stedman's Plus Medical/Pharmaceutical Spellchecker, 2009
by Lippincott Williams & Wilkins (Corporate Author)



Lipodrene Xtreme by Hi-Tech Pharmaceuticals, Inc. - 90 count

Lipodrene Xtreme by Hi-Tech Pharmaceuticals, Inc. - 90 count
by Hi-Tech Pharmaceuticals, Inc.

For Advanced Appetite Control and Metabolic Stimulation BENEFITS: Key Benefits of Lipodrene Xtreme Increases the metabolic rate promoting thermogenesis (the burning of stored body fat) Slows the absorption of serotonin which helps in weight management by controlling food cravings and supressing the appetite. Inhibits the absorption of dietary fats by acting as a lipase inhibitor. Lipodrene Xtreme utilizes highly advanced manufacturing technology and unique proprietary ingredients. Hi-Tech believes that this revolutionary formulation will yield results superior to that of ephedra. How Soon Should Lipodrene Xtreme Begin to Work for Me? You should feel the energizing effects in approximately 30 minutes which may last up to six hours. There is no set amount of weight loss however you...

Pharmaceutical Executive

Pharmaceutical Executive
by Advanstar Communications Inc

Designed to meet the management and marketing needs of professionals in the pharmaceutical industry. Provides information on marketing, sales, promotion, legal and regulatory issues.

Hi-Tech Dianabol, 90 Tablets

Hi-Tech Dianabol, 90 Tablets
by Hi-Tech Pharmaceuticals

Hi-Tech Dianabol, 90 tabs

Aquarium Pharmaceuticals? Algaefix (16 oz.)

Aquarium Pharmaceuticals? Algaefix (16 oz.)
by Aquarium Pharmaceuticals, API, MARS Fishcare

A revolutionary new product for controlling many types of algae in freshwater aquariums containing live plants and fish. ÿKeeps freshwater aquariums clean and clear.16 oz. bottle (473 ml)

Nve Pharmaceuticals 133EA 2oz. 6-Hour Sugar-Free Power Energy Shots - Juicy Grape Flavor (12 Each)

Nve Pharmaceuticals 133EA 2oz. 6-Hour Sugar-Free Power Energy Shots - Juicy Grape Flavor (12 Each)
by Nve Pharmaceuticals

Nve Pharmaceuticals 133EA 2oz. 6-Hour Sugar-Free Power Energy Shots - Juicy Grape Flavor (12 Each)

The Truth About the Drug Companies: How They Deceive Us and What to Do About It

The Truth About the Drug Companies: How They Deceive Us and What to Do About It
by Marcia Angell (Author)

During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue...

© 2009 BrightSurf.com